Trust plans sale of 748 AVAV common shares
A trust associated with AVAV, the STEPHEN F. PAGE LIVING TRUST U/A DTD 02/18/2009, has notified of an intention to sell 748 common shares through Morgan Stanley Smith Barney LLC, with an aggregate value of 107315.56, on or after 07/15/2026 on NASDAQ.
Rhea-AI Filing Summary
A trust associated with AVAV, the STEPHEN F. PAGE LIVING TRUST U/A DTD 02/18/2009, has notified of an intention to sell 748 common shares through Morgan Stanley Smith Barney LLC, with an aggregate value of 107315.56, on or after 07/15/2026 on NASDAQ.
The shares to be sold were acquired as Restricted Stock Units from the issuer on 07/11/2025. Over the prior three months, the trust completed labeled 10b5-1 Sales of 250 shares for 43602.50 on 06/15/2026 and 250 shares for 40577.50 on 05/15/2026.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Form 144 financial
Restricted Stock Units financial
10b5-1 Sales financial
Executive Financial Services financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is planned for AVAV by the Stephen F. Page Living Trust?
Which broker and market are involved in the planned AVAV Form 144 sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.